Resources

Kenya’s Health NGOs Network (HENNET) is a network of over 100 civil society organizations (CSOs) working in health across all 47 counties in Kenya. HENNET coordinates and promotes the engagement of these CSOs to advocate for advancements in health policy.A member of HENNET since its inception, in 2019, PATH began providing consistent, strategic advocacy technical support to HENNET to increase its effectiveness by strengthening the network’s technical capacities, partnership management, operational functions, and financial management systems. Through PATH’s support, HENNET has increased its visibility and presence across critical health decision-making tables, contributed to and influenced key policy decisions, and strengthened its position as the national convener of health CSOs in Kenya.This brief details our partnership with HENNET to strengthen their capacity as part of our approach to driving sustainable policy change.

Since 2016, PATH has supported the Kakamega County Maternal, Newborn, and Child Health Civil Society Organizations Alliance (MNCH CSO Alliance) to advocate with local policymakers to advance the health of women and children in Kakamega.With Kenya’s devolved system of government bringing power and decision-making closer to the people, PATH recognized an opportunity to enable local partners to lead advocacy efforts and demand accountability from their own governments. Beginning in 2019, we took steps to transition leadership of the Alliance to a locally led organization that continues to lead the group today.Over the past several years, the Alliance has been instrumental in strengthening the MNCH policy landscape in the county. This brief details how PATH worked with the Alliance to strengthen their capacity to conduct key advocacy activities that have resulted in tangible improvements to the health system.

Noncommunicable diseases (NCDs), including mental health conditions, present a significant challenge to public health and economies globally. The impact of NCDs and mental health conditions is particularly pronounced in the Asia–Pacific region, with a disproportionate burden on low– and middle–income countries.Through a joint effort, PATH and Asian Development Bank aim to drive the adoption of innovative technologies to elevate the management of NCDs and mental health at the primary care level.Together, we launched the ‘Technologies Beyond Borders’ innovations challenge to identify two well–suited innovations for implementation in primary health care settings, to enhance person–centered, high–quality care for NCDs and mental health. These selected technologies will receive support for feasibility assessment and preparation for deployment in primary health care facilities within the targeted Developing Member Countries in the Asian Development Bank portfolio, specifically Bangladesh, Indonesia, Vietnam and Uzbekistan.This compendium is a collection of promising innovations that emerged from the challenge, demonstrating great potential to make a significant impact on public health systems in low– and middle–income countries in the coming years.

Part 2 of "Tools for advancing maternal, newborn and child health (MNCH) advocacy and accountability from subnational to global levels," the second in our Africa regional MNCH advocacy dialogues series, was held on July 3, 2024.It featured a moderated discussion with panelists from PATH, Samasha Medical Foundation, and the Partnership for Maternal, Newborn, and Child Health. The resources below include the presentations delivered by the panelists and recordings of the webinar in both English and French.

This is a simple, Excel-based tool for assessing and comparing financial costs of pneumococcal conjugate vaccine (PCV) vaccination programs with each PCV product available in the global market. It aims to help country-level policymakers specifically in middle-income countries compare products and estimate vaccination program costs for different PCVs, exploring up to four different vaccine options at a time. The tool calculates cold chain volume and costs annually and for a total period of five years. Cost estimates are composed of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery).It is important to note that cost is only one consideration when selecting a PCV product, and users involved in decision-making around new vaccine introduction/switch or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages below. For questions or support, contact PATH’s Health Economics & Outcomes Research team: HEOR@path.org.NOTE: Please refer to this web page for the most up-to-date version of the calculator, which is periodically updated to reflect the evolving vaccine landscape.